Shared Genetic Architecture and Casual Relationship Between Leptin Levels and Type 2 Diabetes: Large-scale Cross-trait Meta-analysis and Mendelian Randomization Analysis
Overview
Authors
Affiliations
Objective: We aimed to estimate genetic correlation, identify shared loci and test causality between leptin levels and type 2 diabetes (T2D).
Research Design And Methods: Our study consists of three parts. First, we calculated the genetic correlation of leptin levels and T2D or glycemic traits by using linkage disequilibrium score regression analysis. Second, we conducted a large-scale genome-wide cross-trait meta-analysis using cross-phenotype association to identify shared loci between trait pairs that showed significant genetic correlations in the first part. In the end, we carried out a bidirectional MR analysis to find out whether there is a causal relationship between leptin levels and T2D or glycemic traits.
Results: We found positive genetic correlations between leptin levels and T2D (R=0.3165, p=0.0227), fasting insulin (FI) (R=0.517, p=0.0076), homeostasis model assessment-insulin resistance (HOMA-IR) (R=0.4785, p=0.0196), as well as surrogate estimates of β-cell function (HOMA-β) (R=0.4456, p=0.0214). We identified 12 shared loci between leptin levels and T2D, 1 locus between leptin levels and FI, 1 locus between leptin levels and HOMA-IR, and 1 locus between leptin levels and HOMA-β. We newly identified eight loci that did not achieve genome-wide significance in trait-specific genome-wide association studies. These shared genes were enriched in pancreas, thyroid gland, skeletal muscle, placenta, liver and cerebral cortex. In addition, we found that 1-SD increase in HOMA-IR was causally associated with a 0.329 ng/mL increase in leptin levels (β=0.329, p=0.001).
Conclusions: Our results have shown the shared genetic architecture between leptin levels and T2D and found causality of HOMA-IR on leptin levels, shedding light on the molecular mechanisms underlying the association between leptin levels and T2D.
Brito Nunes C, Borges M, Freathy R, Lawlor D, Qvigstad E, Evans D Metabolites. 2024; 14(9).
PMID: 39330515 PMC: 11434570. DOI: 10.3390/metabo14090508.
Chen X, Mei X, Ren Z, Chen S, Tong Y, Zhang C Heliyon. 2024; 10(13):e33704.
PMID: 39040376 PMC: 11261017. DOI: 10.1016/j.heliyon.2024.e33704.
Genome-wide association study and polygenic score assessment of insulin resistance.
Aliyu U, Ismail Umlai U, Toor S, Elashi A, Al-Sarraj Y, Abou Samra A Front Endocrinol (Lausanne). 2024; 15:1384103.
PMID: 38938516 PMC: 11208314. DOI: 10.3389/fendo.2024.1384103.
Meeks K, Bentley A, Assimes T, Franceschini N, Adeyemo A, Rotimi C Genome Med. 2023; 15(1):108.
PMID: 38049854 PMC: 10694992. DOI: 10.1186/s13073-023-01263-7.
Inter-organ crosstalk during development and progression of type 2 diabetes mellitus.
Xourafa G, Korbmacher M, Roden M Nat Rev Endocrinol. 2023; 20(1):27-49.
PMID: 37845351 DOI: 10.1038/s41574-023-00898-1.